Prolonged Time to Surgery in Patients With Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde Overtoom, Bas P. L. Wijnhoven, J.J.B. van Lanschot et al.|Annals of Surgery|2024Cited by 8
Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern <i>versus</i> Western countries: meta-analysisXing Gao, J. Jan B. van Lanschot, Hidde Overtoom et al.|British journal of surgery|2024Cited by 2
796 OUTCOMES OF DELAYED SURGERY IN PATIENTS WITH RESIDUAL DISEASE AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR OESOPHAGEAL CANCERHidde Overtoom, J. Jan B. van Lanschot, Ben M. Eyck et al.|Diseases of the Esophagus|2021Cited by 0